Jim Cramer Discussed These 12 Stocks Recently

4. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 86

Cramer highlighted that Merck & Co., Inc. (NYSE:MRK) has been suffering because of China as he remarked:

“Oh, let’s not forget how well Merck could be doing if the Chinese government didn’t slow play the rollout of the Gardasil vaccine for no particular reason other than forget it… it’s China… I mean honestly, what the heck happened there?”

Merck (NYSE:MRK) provides pharmaceutical products across various health areas, including oncology and vaccines, and develops veterinary medicines. The company also collaborates with other firms on cancer therapies and novel treatments. In January, Cramer said:

“They (the company) also have a shot, Gardasil, that protects against HPV. It’s [a] very common STD, that can cause cervical cancer. It’s a true lifesaver. Women have been using it for years. [The] Chinese government recently approved it for men too. But for some reason, Merck’s having a problem with its Chinese distribution and women. Weird situation going on over there. Right now, the stock’s well-ensconced a few points around 52-week low.”